InvestorsHub Logo
icon url

barbershop

12/31/12 10:21 AM

#32831 RE: MagicCap #32808

Michaeland1...To me the patent situation is what gives AMBS the most leverage.

Amarantus owns composition of matter and method of use patents for MANF, including claims for use of MANF as a protein therapy, gene therapy and as an adjuvant within the context of cell therapy.

Very good sign if a partnership should be done with AMBS in the future. Strong leveraging point.